Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|November 2, 2006
Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapyAnhua Wu, Steve Wiesner, Jing Xiao, et al.
Cancer Research|September 14, 2013
GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-αGary Kohanbash, Kayla McKaveney, Masashi Sakaki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastomaAnhua Wu, Seunguk Oh, Soheila Gharagozlou, et al.
Cancer Research|February 18, 2011
COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cellsMitsugu Fujita, Gary Kohanbash, Wendy Fellows-Mayle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013
Profound impairment of adaptive immune responses by alkylating chemotherapyAdam J Litterman, David M Zellmer, Karen L Grinnen, et al.
Journal for Immunotherapy of Cancer|February 18, 2016
Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvantBrian M Andersen, Junzhe Xia, Alan L Epstein, et al.
Drug Delivery and Translational Research|March 20, 2015
Immunotoxin targeting CD133(+) breast carcinoma cellsJohn R Ohlfest, David M Zellmer, Jayanth Panyam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2012
Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma modelJohn R Ohlfest, Brian M Andersen, Adam J Litterman, et al.
Pageof 6